Treatment response and microRNA profiles in triple negative breast cancer patients receiving standard chemotherapy (TARMAC)
The following grant was awarded by, is supported by, is administered by or is in partnership with the Fogarty International Center at the U.S. National Institutes of Health (NIH).
Funding Fogarty Program
Emerging Global Leader
Project Information in NIH RePORTER
Treatment response and microRNA profiles in triple negative breast cancer patients receiving standard chemotherapy (TARMAC)
Principal Institution
University of Ibadan College of Medicine
Principal Investigator(s) (PI)
Ntekim, Atara Isaiah
Project Contact Information
Email: kimata2000@hotmail.com
Year(s) Awarded
2018-2023
Country
Nigeria
NIH Partners
NCI
Project Description
This project has the potential to reduce the high death rate associated with a deadly type of breast cancer known as triple negative breast cancer, which is predominantly diagnosed among indigenous black women, and therefore of great public health importance. The mentored career development activities of this award will lead to a better understanding of how to design and conduct clinical trials that will discover effective cancer treatment strategies relevant to low- and middle-income countries. There is a dearth of experts in cancer clinical trial design and implementation in low- and middle-income countries, and this award will help build local capacity to address this shortage.
Related World Regions / Countries
Related Global Health Research Topics